 STAMFORD, Conn., Jan. 03, 2022 GLOBE NEWSWIRE -- Cara Therapeutics, Inc. Nasdaq: CARA, an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present a company overview at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 11:15 a.m. ET. 